Pharmaceuticals Stocks

Regeneron Pharmaceuticals Inc Valuation – February 2019 $REGN

Regeneron Pharmaceuticals Inc is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios.

Read More
Back To Top